K.J. Harrison & Partners Inc Bria Cell Therapeutics Corp. Transaction History

K.J. Harrison & Partners Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$5.72 - $7.58 $407,795 - $540,400	-71,293 Reduced 67.3%	34,640 $222,000
Q1 2023 Apr 24, 2023	SELL	$4.59 - $7.99 $1.48 Million - $2.57 Million	-321,650 Reduced 75.23%	105,933 $789,000
Q4 2022 Jan 25, 2023	SELL	$4.28 - $6.03 $223,651 - $315,097	-52,255 Reduced 10.89%	427,583 $0
Q3 2022 Oct 21, 2022	SELL	$3.0 - $8.31 $3.38 Million - $9.37 Million	-1,127,189 Reduced 70.14%	479,838 $2.75 Million
Q2 2022 Jul 27, 2022	BUY	$4.28 - $11.9 $1.09 Million - $3.04 Million	255,245 Added 18.88%	1,607,027 $9.19 Million

Q1 2022 Apr 21, 2022	BUY	$5.91 - $10.14 $7.99 Million - $13.7 Million	1,351,782 New	1,351,782 $13.7 Million

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $16M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.